Genotyping Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Genotyping Market By Product Type (Instruments, Reagents & Kits, Genotyping Services, Software, and Services), Technology (Real-time PCR, Digital PCR, Sequencing, Microarrays, Capillary Electrophoresis, MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight), and Other Technologies) Application Type (Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, Diagnostic & Personalized Medicine, and Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies Treatment Applications, Research Applications), End User (Diagnostic and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Academic Institutes, and Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Genotyping Market size is expected to be worth USD 12.3 billion in 2022, growing at a 20.6% CAGR from 2022 to 2028. Genotyping is a laboratory process in which an individual’s DNA is analyzed for specific nucleotides or bases to determine whether certain variants are present. Genotyping by sequencing also supports performing a comparative analysis of samples without knowing a reference genome. With the increasing incidence of genetic diseases, genotyping products are needed for the treatment. Hence, increasing adoption of genotyping products and rising awareness of personalized medicine is expected to support the market growth in the coming years. Technological advancement in products for better results with maximum efficiency and precision will give the chance to critical players for making investments which will expand the Market.  Nowadays, developed and developing regions are looking forward to advanced technology for the improvements to healthcare infrastructure would undoubtedly lead to the market growth rate in the forecasted period. The COVID-19 pandemic viewed a positive impact on the genotyping market, as the pandemic led to an increased demand for COVID-19 genotyping kits. Furthermore, the genotyping market will continuously grow with advancements in products and investing in better health care infrastructure.

Recent Market Developments:

In May 2022, Neogen and Gencove launched InfiniSEEK™ – The First Whole Genome and Genotyping Sequencing Solution for Cattle Breeders

In Sep 2020, Omixon launched Omnitype, a multiplex for NGS-based HLA genotyping

In Jun 2021, The Centre for Aquaculture Technologies (CAT) and Neogen  had a partnership plan to customize service by applying modern sequencing and genotyping technologies to aquaculture species, leveraging their complementary expertise

Genotyping Market

MARKET SUMMARY
-
20.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 20.6%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

Genotyping Market

  • The global genotyping market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global genotyping market gives historical, current, and future market sizes on the basis of product type, technology, application, end-user, and geography.
Key Players
  • AbbVie Inc.
  • Pfizer Inc.
  • Bayer AG
  • Boehringer Ingelheim
  • Eli Lilly and Company
Genotyping Market Dynamics

The major factors expected to be driving the genotyping assay market are technological advancements and the feasible prices of DNA sequencing. The growing incidence of genetic diseases and rising awareness of personalized medicine, the rising importance of genotyping in drug development and discoveries, and the increasing demand for bioinformatics solutions in data examination are also projected to promote market growth in the coming years. Also, the genotyping market is expanding due to the rising incidence of genetic disorders. With the advancement of PCR, capillary electrophoresis, sequencing, and microarray technologies for accurate and precise sequencing, high productivity. Moreover, these developments and advancements will create lucrative opportunities during the forecast period. The steady growth of the genotyping market is constrained by the high cost of instruments, kits & reagents uses in treatment.


North-America Got Significant Share

Genotyping Market

The Genotyping Market in North America is estimated to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase speedily. The increasing adoption of technologically advanced products, the existences of major pharmaceutical & biopharmaceutical companies, proactive government programs and funding, highly advanced and developed healthcare infrastructure, and the presence of key players in this region are the factor accountable for the high market share in the region. Europe is correspondingly anticipated to exhibit opportunities to enter the genotyping market with technological advancements and the growing pharma and biopharma sector in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The genotyping market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Genotyping Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The genotyping market is projected to expand at a CAGR of 20.6% during the forecast period

Bio-Rad Laboratories Inc., Illumina Inc., Agilent Technologies, Thermo Fisher Scientific Inc., GE Healthcare Inc., Qiagen Inc., Neogen Corporation, Gencova Diagnostics, Hoffmann-La Roche Ltd.

North America is the fastest-growing region for genotyping market


Report

Table Of Content

1. Executive Summary
2. Global Genotyping Market Introduction
2.1. Global Genotyping Market – Taxonomy
2.2. Global Genotyping Market –Definitions
2.2.1. Product Type
2.2.2. Technology Type
2.2.3. Application Type
2.2.4. End User
2.2.5. Geography
3. Global Genotyping Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Genotyping Market Dynamic Factors – Impact Analysis
3.6. Global Genotyping Market – Competition Landscape
4. Global Genotyping Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Genotyping Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Analyzers
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Sequencers & Amplifier
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Reagents & Kits
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3.  Genotyping Services
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Software and Services
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Genotyping Market, By Technology Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Real-time PCR
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Digital PCR
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Sequencing
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Microarrays
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Capillary Electrophoresis
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Other Technologies
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Genotyping Market Forecast, By Application, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Agricultural Biotechnology
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Pharmacogenomics
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Animal Genetics
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Diagnostic & Personalized Medicine
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies)
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Genotyping Market, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Diagnostic and Research Laboratories
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical and Biopharmaceutical Companies
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic Institutes
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Genotyping Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Genotyping Market – Opportunity Analysis Index, By Product Type, Technology Type, Application Type, End User and Region, 2022 – 2028
10. North America Genotyping Market Analysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
10.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.1.1. Analyzers
10.1.1.2. Sequencers & Amplifier
10.1.2. Reagents & Kits
10.1.3. Genotyping Services
10.1.4. Software and Services
10.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Real-time PCR
10.2.2. Digital PCR
10.2.3. Sequencing
10.2.4. Microarrays
10.2.5. Capillary Electrophoresis
10.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
10.2.7. Other Technologies
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Agricultural Biotechnology
10.3.2. Pharmacogenomics
10.3.3. Animal Genetics
10.3.4. Diagnostic & Personalized Medicine
10.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies)
10.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Diagnostic and Research Laboratories
10.4.2. Pharmaceutical and Biopharmaceutical Companies
10.4.3. Academic Institutes
10.4.4. Others
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Genotyping Market – Opportunity Analysis Index, By Product Type, Technology, Application, End User and Country, 2022 – 2028
10.7. North America Genotyping Market Dynamics – Trends
11. Europe Genotyping Market Analysis, 2017–2021 and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.1.1. Analyzers
11.1.1.2. Sequencers & Amplifier
11.1.2. Reagents & Kits
11.1.3. Genotyping Services
11.1.4. Software and Services
11.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Real-time PCR
11.2.2. Digital PCR
11.2.3. Sequencing
11.2.4. Microarrays
11.2.5. Capillary Electrophoresis
11.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
11.2.7. Other Technologies
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Agricultural Biotechnology
11.3.2. Pharmacogenomics
11.3.3. Animal Genetics
11.3.4. Diagnostic & Personalized Medicine
11.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies)
11.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Diagnostic and Research Laboratories
11.4.2. Pharmaceutical and Biopharmaceutical Companies
11.4.3. Academic Institutes
11.4.4. Others
11.5. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Genotyping Market – Opportunity Analysis Index, By Product Type, Technology, Application Type, End User and Country, 2022 – 2028
11.7. Europe Genotyping Market Dynamics – Trends
12. Asia-Pacific Genotyping Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017–2021 and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.1.1. Analyzers
12.1.1.2. Sequencers & Amplifier
12.1.2. Reagents & Kits
12.1.3. Genotyping Services
12.1.4. Software and Services
12.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Real-time PCR
12.2.2. Digital PCR
12.2.3. Sequencing
12.2.4. Microarrays
12.2.5. Capillary Electrophoresis
12.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
12.2.7. Other Technologies
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Agricultural Biotechnology
12.3.2. Pharmacogenomics
12.3.3. Animal Genetics
12.3.4. Diagnostic & Personalized Medicine
12.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies)
12.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Diagnostic and Research Laboratories
12.4.2. Pharmaceutical and Biopharmaceutical Companies
12.4.3. Academic Institutes
12.4.4. Others
12.5. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Genotyping Market – Opportunity Analysis Index, By Product Type, Technology Type, Application Type, End User and Country,2022 – 2028
12.7. Asia-Pacific Genotyping Market Dynamics – Trends
13. Latin America Genotyping Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn)
13.1. Product Type Analysis 2017–2021 and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.1.1. Analyzers
13.1.1.2. Sequencers & Amplifier
13.1.2. Reagents & Kits
13.1.3. Genotyping Services
13.1.4. Software and Services
13.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Real-time PCR
13.2.2. Digital PCR
13.2.3. Sequencing
13.2.4. Microarrays
13.2.5. Capillary Electrophoresis
13.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
13.2.7. Other Technologies
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Agricultural Biotechnology
13.3.2. Pharmacogenomics
13.3.3. Animal Genetics
13.3.4. Diagnostic & Personalized Medicine
13.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies)
13.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Diagnostic and Research Laboratories
13.4.2. Pharmaceutical and Biopharmaceutical Companies
13.4.3. Academic Institutes
13.4.4. Others
13.5. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Genotyping Market – Opportunity Analysis Index, By Product Type, Technology, Application Type, End User and Country, 2022 – 2028
13.7. Latin America Genotyping Market Dynamics – Trends
14. Middle East and Africa Genotyping Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.1.1. Analyzers
14.1.1.2. Sequencers & Amplifier
14.1.2. Reagents & Kits
14.1.3. Genotyping Services
14.1.4. Software and Services
14.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Real-time PCR
14.2.2. Digital PCR
14.2.3. Sequencing
14.2.4. Microarrays
14.2.5. Capillary Electrophoresis
14.2.6. MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization-Time of Flight)
14.2.7. Other Technologies
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Agricultural Biotechnology
14.3.2. Pharmacogenomics
14.3.3. Animal Genetics
14.3.4. Diagnostic & Personalized Medicine
14.3.5. Other Applications (Human Forensics, Aquaculture Breeding Studies, and Microbial Genomic Studies)
14.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Diagnostic and Research Laboratories
14.4.2. Pharmaceutical and Biopharmaceutical Companies
14.4.3. Academic Institutes
14.4.4. Others
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Genotyping Market – Opportunity Analysis Index, By Product Type, Technology Type, Application, End User and Country, 2022 – 2028
14.7. MEA Genotyping Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Bio-Rad Laboratories Inc.
15.2.2. Illumina Inc.
15.2.3. Agilent Technologies
15.2.4. Thermo Fisher Scientific Inc.
15.2.5. GE Healthcare Inc.
15.2.6. Qiagen Inc.
15.2.7. Neogen Corporation
15.2.8. Gencova Diagnostics
15.2.9. F. Hoffmann-La Roche Ltd.
15.2.10. Fluidigm Corporation
15.2.11. Danaher Corporation
15.2.12. Eurofins Scientific
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Agilent Technologies
  • Thermo Fisher Scientific Inc.
  • GE Healthcare Inc.
  • Qiagen Inc.
  • Neogen Corporation
  • Gencova Diagnostics
  • Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • Danaher Corporation
  • Eurofins Scientific

Description

Genotyping Market size is expected to be worth USD 12.3 billion in 2022, growing at a 20.6% CAGR from 2022 to 2028. Genotyping is a laboratory process in which an individual’s DNA is analyzed for specific nucleotides or bases to determine whether certain variants are present. Genotyping by sequencing also supports performing a comparative analysis of samples without knowing a reference genome. With the increasing incidence of genetic diseases, genotyping products are needed for the treatment. Hence, increasing adoption of genotyping products and rising awareness of personalized medicine is expected to support the market growth in the coming years. Technological advancement in products for better results with maximum efficiency and precision will give the chance to critical players for making investments which will expand the Market.  Nowadays, developed and developing regions are looking forward to advanced technology for the improvements to healthcare infrastructure would undoubtedly lead to the market growth rate in the forecasted period. The COVID-19 pandemic viewed a positive impact on the genotyping market, as the pandemic led to an increased demand for COVID-19 genotyping kits. Furthermore, the genotyping market will continuously grow with advancements in products and investing in better health care infrastructure.

Recent Market Developments:

In May 2022, Neogen and Gencove launched InfiniSEEK™ – The First Whole Genome and Genotyping Sequencing Solution for Cattle Breeders

In Sep 2020, Omixon launched Omnitype, a multiplex for NGS-based HLA genotyping

In Jun 2021, The Centre for Aquaculture Technologies (CAT) and Neogen  had a partnership plan to customize service by applying modern sequencing and genotyping technologies to aquaculture species, leveraging their complementary expertise

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX